COMPANY

Degron Therapeutics

Profile checked Oct 10, 2026

Keywords: DEG6498

Timeline

Nov 13, 2025 Trial start Phase 1: A Study of DEG6498 in Participants With Solid Tumors source ↗

2028-12 (ESTIMATED) · Phase 1 · A Study of DEG6498 in Participants With Solid Tumors · NCT07244835

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07244835	A Study of DEG6498 in Participants With Solid Tumors	Phase 1	Recruiting	Nov 13, 2025	2028-12 (estimated)